L9: Drugs and the Parasympathetic Nervous System Flashcards

1
Q

What is the classification of peripheral nervous system?

A
  • somatic (skeletal muscle, voluntary)
  • autonomic (smooth and cardiac muscle, exocrine glands)
    i) sympathetic (Fight/Flight)
    ii) parasympathetic (rest/repose)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What are the different cholinergic receptors in parasympathetic nervous system?

A
  • Nicotinic:
    i) neuronal (brain OR ganglionic)
  • Muscarinic:
    i) M 1, 3, 5 (Gq/11);
    ii) M 2, 4 (Gi/Go)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What is the reaction of Acetylcholine synthesis?

A

Acetyl CoA + Choline –> Acetylcholine + CoA
By choline acetyltransferase

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

In which pathology is choline acetyltransferase implicated?

A

Alzheimer’s disease

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What does hemicholinium do in regard to acetylcholine synthesis?

A

Hemicholinium blocks the transport of choline into the nerve terminal. (no therapeutic use, but pharmacological tool)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What does vesamicol do in regard to acetylcholine storage?

A

Vesamicol inhibits transport of acetylcholine into vesicles

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What does tetrodotoxin do in regard to acetylcholine release?

A

Tetrodotoxin is the toxin found in the Puffer fish, blocks voltage gated Na+ channels, stopping an AP from being generated in a nerve and thus blocking AP-dependent release of neurotransmitter from nerve terminals

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

How does botulinum toxin affect synaptic vesicles?

A

It prevents fusion of synaptic vesicles with membrane of the presynaptic terminal

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What are the therapeutic uses of botulinum toxin?

A

Treatment of:
- persistent and disabling eyelid spasm
- excessive extensor muscle tone (hypertonia, muscle stiff and hard to move)
- bladder over activity
- squint (injection into extra ocular muscles)
- excessive salivary secretion or sweating

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What are neuromuscular blockers? What are they classified as? What are they used for usually?

A

Clinically useful drugs that act to block the interaction of acetylcholine with the nicotinic receptor. Used for general anaesthesia. Classified as:
- non-depolarizing
- depolarizing antagonists.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What are non-depolarizing blockers?

A

They compete with acetylcholine for the agonist binding site on the nAChRs, they competitive receptor antagonists (block neurotransmission)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

How can the action of non-depolarizing blockers be overcome?

A

It can be overcome by the administration of an anti-cholinesterase drug.
Increasing [agonist] in the synaptic cleft increases the probability that an agonist molecule will occupy the binding site on the receptor-channel rather than an antagonist molecule.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

When are neuromuscular blockers often used?

A

Commonly they are used as adjuncts to general anaesthesia.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What’s the action of atracurium in terms of non-depolarizing blockers? (onset; duration; side effects, usage)

A
  • onset: intermediate
  • duration: <30min
  • side effects: transient hypo
  • usage: +++
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What’s the action of Pancuronium in terms of non-depolarizing blockers? (onset; duration; side effects, usage)

A
  • onset: intermediate
  • duration: long
  • side effects: sI tachycardia
  • usage: +++
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What are depolarizing blockers? Give an example (chemical nature, mechanism of action, duration of action; side effects)

A
  • Depolarizing blockers activate the nicotinic receptor.
  • Suxamethonium - only depolarizing blocker used clinically.
  • Chemical nature: two acetylcholine molecules linked by their acetyl groups.
  • Mechanism of Action: It produces a small amount of sustained depolarisation at the endplate, that ultimately cause the nicotinic receptors to inactivate - i.e. the pore does not open in response to the binding of agonist.
  • Duration of action: It’s broken down by cholinesterase, so short duration of action. Used for brief procedures.
  • Side effects: bradycardia, potassium release, raise intraocular pressure; prolonged paralysis in individuals with low plasma cholinesterase levels or in those receiving anti-cholinesterase drugs.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

What’s the mechanism of action of Suxamethonium in terms of depolarizing blockers?

A

Mechanism of Action: It produces a small amount of sustained depolarisation at the endplate, that ultimately cause the nicotinic receptors to inactivate - i.e. the pore does not open in response to the binding of agonist.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

What’s the duration of action of Suxamethonium in terms of depolarizing blockers? Why is it like that?

A

Duration of action: It’s broken down by cholinesterase, so short duration of action. Used for brief procedures.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

What are the side effects of Suxamethonium in terms of depolarizing blockers?

A

Side effects:
- bradycardia,
- potassium release,
- raised intraocular pressure;
- prolonged paralysis in individuals with low plasma cholinesterase levels or in those receiving anti-cholinesterase drugs.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

How can the action of depolarizing blockers be overcome?

A

The block produced by a depolarizing blocker is NOT relieved by an anti-cholinesterase.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

What are parasympathomimetic or cholinomimetic drugs?

A

Drugs that mimic the effects of parasympathetic nerve stimulation, particularly by activation of responses mediated by muscarinic cholinergic receptors.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

What are the effectors of muscarinic receptor activation?

A

Mucarinic receptors can:
- activate phospholipase C to cause production of IP3 and diacyl glycerol (second messengers)
- inhibit adenylate cyclase causing a decrease in the levels of cAMP
- activate K+ channels and inhibit Ca2+ channels (hyperpolarisation)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

What are the main subtypes of muscarinic receptor? What are their functions?

A
  • M1 receptors - neural (slow EPSP in ganglia)
  • M2 receptors - cardiac (decrease rate and force of contraction; heart)
  • M3 receptors - secretion, contraction of visceral smooth muscle, vascular relaxation
  • M4 and M5 receptors - found in CNS
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

What is the classification of direct acting agonists? What are their examples?

A
  • choline esters (acetylcholine, methacoline, carbachol, bethanecol)
  • natural plant compounds (pilocarpine, muscarine)
25
Q

What are choline esters? Give examples and their action (efficacy) on muscarinic and nicotinic AChRs.

A

Choline esters have similar structure to acetylcholine and they’re all quaternary ammonium compounds. (Direct acting agonists)
- acetylcholine - too unstable in plasma to be an effective drug. Has both muscarinic and nicotinic effect. Quickly hydrolyzed by esterases.
- methacoline - has therapeutic use, as not so quickly hydrolyzed by esterases, higher action on muscarinic than nicotinic AChRs
- carbachol - not hydrolyzed by esterases, higher action on nicotinic than muscarinic AChRs
- bethanecol - not hydrolyzed by cholinesterase. Very weak nicotinic agonist, primarily a muscarinic agonist

26
Q

What are natural plant compounds? Give examples and their action on muscarinic and nicotinic AChRs.

A
  • pilocarpine - alkaloid primarily with muscarinic actions. Tertiary amine, lipophilic - crosses biological membranes. Has therapeutic use.
  • muscarine - the defining muscarinic agonist from Amanita muscaria mushrooms. Of interest due to potential poisoning.
27
Q

What are the main pharmacological actions of direct acting drugs?

A
  • have mainly muscarinic effects at end effectors
  • can have nicotinic effects at ganglia that amplify muscarinic effects
  • have some adrenergic effects at ganglia due to stimulation of ganglia and adrenal medulla
  • most synthetic direct acting compounds do not have CNS effects
  • plant alkaloid muscarine and pilocarpine can enter CNS
28
Q

What are the effects of autonomic receptor activation regarding sympathetic and parasympathetic systems? (Veins, arterioles; heart; bronchi; iris (radial); iris (pupil constrictor); ciliary muscle; GI tract; salivary glands)

A

Organ; sympathetic action; parasympathetic action
- veins arterioles; constriction; dilation
- heart; increase rate, force; decrease rate, force
- bronchi; relaxation; contraction
- iris (radial); contraction; none
- iris (pupil constrictor); none; contraction
- ciliary muscle; relaxation; contraction
- GI tract; relaxation; contraction
- salivary glands; increase secretion; decrease secretion

FOR A DETAILED TABLE CHECK L9, SLIDE 28

29
Q

What are the therapeutic uses for cholinomimetics?

A
  • Glaucoma
  • intestinal atony
  • urinary bladder atony (incomplete emptying of the bladder)
30
Q

What’s the cholinomimetic drug used to treat glaucoma? What is its mechanism?

A

Pilocarpine (direct acting agonist), diffuse rapidly locally throughout the eye. Cannot be given systematically due to effects of CNS, but local administration is fine. Mechanism: problem in glaucoma - secretion of aqueous humor or drainage of aqueous humor. Buildup of intraoccular pressure is painful, damages optic nerve and retina. Contraction of the pupil constrictor (miosis) and ciliary muscle by muscarinic receptor activation widens anterior angle of eye and promotes drainage of aqueous humour through Canal of Schlemm.

31
Q

What’s the cholinomimetic drug used to treat intestinal atony, urinary bladder atony? What is its mechanism?

A

bethanecol (direct acting agonist), neostigmine (indirect acting agonist)
Mechanism: increase peristalsis (involuntary contraction and relaxation of muscle) by activation of muscarinic receptors. Stimulate micturition (action of urinating) by activating muscarinic receptors on bladder detrusor muscle. Useful in postpartum or postoperative non-obstructive urinary retention.

32
Q

What are competitive muscarinic antagonists? How do they act? Give examples

A

Antimuscarinic drugs, all functions mediated by muscarinic receptors are blocked by these drugs, inhibit muscarinic receptor, effect is highly restricted, no effect on skeletal muscle cholinergic neurons.
Examples:
- atropine - prototypical muscarinic antagonist
- hyoscine - more lipophilic can be absorbed through gut or patch and readily crosses into CNS

33
Q

What are the pharmacological actions of atropine on GI system?

A

In gastrointestinal system atropine decreases motility to complete atony and constipation with large doses and chronic use with modest decrease in GI secretory activity occur

34
Q

What are the pharmacological actions of atropine on eye?

A

eye - atropine causes pupil dilation (mydriasis) due to blockade of cholinergic muscarinic receptors of pupil constrictor muscle. Paralysis of accommodation (cyclopegia, inability to focus) due to blockade of ciliary muscle activity.

35
Q

What are the pharmacological actions of atropine on cardiovascular system?

A

cardiovascular system - atropine causes tachycardia (heart rate increases) since the effects of vagal stimulation are blocked.

36
Q

What are the pharmacological actions of atropine on urinary tract?

A

Atropine decreases bladder motor activity

37
Q

What are the pharmacological actions of atropine on exocrine glands?

A

Primary effect is dry eyes (blockade of lacrimal gland receptors), dry mouth (blockade of salivary gland receptors) and dry skin (blockade of thermoregulatory sweat gland receptors), can elevate body temperature, particularly in children. But does NOT block emotional sweating, moist palms.

38
Q

What are the pharmacological actions of atropine on respiratory tract?

A

Muscarinic antagonists cause bronchodilation and reduced mucous secretions. Valuable for asthma, also drying out tract prior to general anaesthesia.

39
Q

What are the pharmacological actions of atropine on CNS? Where are they used?

A

Mainly excitatory effects. Low doses cause restlesness, higher doses produce hallucinations and disorientation and respiratory depression at fatal dose. Ingestion of belladona berries leads to hyperactivity and a considerable in body temperature. Muscarinic antagonists also have an anti-emetic action. In addition they can be used to reduce involuntary movement and rigidity in patients with Parkinson’s disease

40
Q

What is the therapeutic use of Competitive Muscarinic Antagonists on asthma? Give example of a drug and its mechanism

A

Ipratropium - derivative of atropine (inhaled). Blocks muscarinic receptors in bronchiolar smooth muscle, which antagonizes vagal bronchoconstrictor effects.

41
Q

What is the therapeutic use of Competitive Muscarinic Antagonists on acute myocardial infarction with sinus bradycardia? Give example of a drug and its mechanism

A

Atropine or derivatives. Blockade of SA node muscarinic receptors allows sympathetics dominance. Faster SA rate prevents emergence of ventricular ectopic pacemakers.

42
Q

What is the therapeutic use of Competitive Muscarinic Antagonists on preanaesthetic medication? Give example of a drug and its mechanism

A

Atropine or derivates. Reduction of salivary and bronchial secretions by blockade of muscarinic receptors minimizes postoperative pulmonary complications.

43
Q

What is the therapeutic use of Competitive Muscarinic Antagonists on ophtalmological uses? Give example of a drug and its mechanism

A

Atropine or shorter acting derivatives used topically (e.g. tropicamide). Muscarinic receptor blockade on concentric muscle of iris causes pupil dilation (mydriasis) and on ciliary muscles causes paralysis of accommodation (cyclopegia)

44
Q

What is the therapeutic use of Competitive Muscarinic Antagonists on Parkinson’s disease? Give example of a drug and its mechanism

A

Atropine derivates, benztropine. Muscarinic receptor blockade in basal ganglia helps to restore balance between cholinergic and dopaminergic systems

45
Q

What is the therapeutic use of Competitive Muscarinic Antagonists on treatment of poisoning by cholinomimetics? Give example of a drug and its mechanism

A

Atropine or derivates. For poisoning by direct-acting or indirect acting drugs, anticholinesterase insecticides, Amanita muscaria mushrooms atropine is used to antagonize many of the potentially lethal effects of high levels of muscarinic receptor activation in the periphery and CNS.

46
Q

What is the therapeutic use of Competitive Muscarinic Antagonists on urinary incontinence? Give example of a drug and its mechanism

A

oxybutynin, tolterodine, darifenacin drugs acting on the bladder to inhibit micturition. Inhibition of micturition by antagonism of muscarinic receptors on bladder detrusor muscle.

47
Q

What is the therapeutic use of Competitive Muscarinic Antagonists on treatment of peptic ulcer? Give example of a drug and its mechanism

A

Pirenzepine (M1 selective antagonist). Suppresion of gastric acid secretion.

48
Q

What are the inhibitors of ACh-esterase? What are their classes?

A

Inhibtors of ACH-esterase can prolong lifetime of ACh in junction. There are reversible and irreversible inhibitors.

49
Q

What are the examples of reversible inhibitors of ACh-esterase?

A
  • physostigmine
  • neostigmine
  • insecticide Carbaril
50
Q

What are the examples of irreversible inhibitors of ACh-esterase?

A
  • insecticides (accidental poisoning)
  • ectothiophate (open angle glaucoma)
  • military nerve gases
51
Q

What drug is used for treatment of anti-AChE poisoning? What is its action?

A

Pralidoxime reactivates the enzyme, binds to the anionic site of the enzyme, and removes the phosphate from the serine on the esteric (active) site.

52
Q

What’s the drug and its action of therapeutic inhibition of AChE in glaucoma? What is its mechanism?

A

Physostigmine, echothiophate. As for policarpine, increase drainage angle

53
Q

What’s the drug and its action of therapeutic inhibition of AChE in intestinal atony, urinary bladder atony? What is its mechanism?

A

Neostigmine. Increase persitalsis by activation of muscarinic receptors. Stimulate micturition by activating muscarinic receptors on bladder detrusor muscle. Useful in postpartum or postoperative non-obstructive urinary retention.

54
Q

What’s the drug and its action of therapeutic inhibition of AChE in intoxication by antimuscarinic drugs? What is its mechanism?

A

Physostigmine. Increased concentration of ACh competes with muscarinic blockers and surmounts blockade.

55
Q

What’s the drug and its action of therapeutic inhibition of AChE in reversal of non-depolarizing block at NMJ? What is its mechanism?

A

Physostigmine, neostigmine. Increased concentration of ACh competes competitive antagonist e.g. atricurium and surmounts blockade.

56
Q

What’s the drug and its action of therapeutic inhibition of AChE in alleviating cognitive decline in Alzheimer’s disease? What is its mechanism?

A

Tacrine, donepezil. Balance between cholinergic and dopaminergic systems.

57
Q

What’s the drug and its action of therapeutic inhibition of AChE in Myasthenia gravis? What is its mechanism?

A

Edrophonium is used as diagnostic, neostigmine has longer action for treatment. Increases ACh concentration at neuromuscular junction to increase probability of receptor activation and muscle contraction.

58
Q

What is Myasthenia Gravis?

A

Myasthenia Gravis is an autoimmune disease which is characterized by fluctuating, sometimes fatal, muscle weakness which results from an autoimmune attack against nAChRs at the NMJ

59
Q

For overview of Cholinergic Drugs check L9, slide 51

A